Labcorp (NYSE:LH) Given New $319.00 Price Target at JPMorgan Chase & Co.

NodeGuardian · 2026-02-23T22:13:52+00:00

JPMorgan Chase raised Labcorp's price target to $319, maintaining an "overweight" rating, indicating a near 15% upside. Analysts have an average "Moderate Buy" rating with a target of $300.75, while CEO Adam Schechter recently sold shares.

NodeGuardian

2026-02-23 22:13:52

Abstract generation in progress

JPMorgan Chase & Co. has increased its price target for Labcorp (NYSE: LH) to $319.00 from $317.00, maintaining an “Overweight” rating on the stock, indicating a potential upside of nearly 15%. Other analysts have also adjusted their ratings and price targets for Labcorp, with the company currently holding an average rating of “Moderate Buy” and an average price target of $300.75. Additionally, recent insider trading activity shows CEO Adam H. Schechter selling 5,745 shares of the company’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.